Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Disability-adjusted life years for respiratory syncytial virus in children under 2 years.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: BioMed Central Country of Publication: England NLM ID: 100968562 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2458 (Electronic) Linking ISSN: 14712458 NLM ISO Abbreviation: BMC Public Health Subsets: MEDLINE
    • Publication Information:
      Original Publication: London : BioMed Central, [2001-
    • Subject Terms:
      Respiratory Syncytial Virus Infections*/epidemiology ; Respiratory Syncytial Virus, Human*; Child ; Colombia/epidemiology ; Humans ; Infant ; Quality-Adjusted Life Years
    • Abstract:
      Background: Respiratory syncytial virus infection is the leading cause of bronchiolitis in Colombia. There is growing evidence about the impact of Respiratory syncytial virus on society in terms of years of life lost due to this condition. The objective of the present study is to determine the Disability-Adjusted Life Years for respiratory syncytial virus in children under 2 years in Colombia.
      Methods: Data from the national epidemiological surveillance system were used to estimate DALYs, calculated from the sum of years of life lost and years lived with disability due to RSV infection in Colombia. A bootstrapped method with 10,000 iterations was used to estimate each statistical parameter using the package DALY calculator in R.
      Results: In 2019, 260,873 years of life (CI95% 208,180-347,023) were lost due to RSV bronchiolitis in Colombian children under 2 years. The estimated rate was 20 DALYs / 1000 person-year (95% CI 16-27).
      Conclusion: This is the first report estimating the impact of RSV bronchiolitis morbidity and mortality in Colombia. The findings of the present study suggest that the actual burden and cost of bronchiolitis due to RSV is high. Prevention strategies, such as RSV vaccination, to reduce morbidity associated with RSV infection should be encouraged in our country.
    • References:
      J Med Virol. 2015 May;87(5):774-81. (PMID: 25648409)
      J Pediatr (Rio J). 2013 Nov-Dec;89(6):544-8. (PMID: 24029550)
      J Eval Clin Pract. 2019 Aug;25(4):682-688. (PMID: 31095842)
      Lancet. 2017 Sep 2;390(10098):946-958. (PMID: 28689664)
      Open Microbiol J. 2011;5:144-54. (PMID: 22262987)
      Popul Health Metr. 2003 Apr 14;1(1):4. (PMID: 12773212)
      Lancet. 2010 May 1;375(9725):1545-55. (PMID: 20399493)
      Lancet. 2015 Nov 28;386(10009):2145-91. (PMID: 26321261)
      Rev Panam Salud Publica. 2014 Aug;36(2):101-9. (PMID: 25345531)
      Rev Med Virol. 2014 Mar;24(2):76-89. (PMID: 24757727)
      Allergol Immunopathol (Madr). 2020 Jan - Feb;48(1):56-61. (PMID: 31235183)
      Int J Technol Assess Health Care. 2020 Apr;36(2):173-178. (PMID: 32312340)
      Curr Top Microbiol Immunol. 2013;372:39-57. (PMID: 24362683)
      BMC Pharmacol Toxicol. 2019 Feb 15;20(1):11. (PMID: 30767779)
      BMC Public Health. 2014 Feb 11;14:147. (PMID: 24517715)
      Pharmacoecon Open. 2020 May 16;:. (PMID: 32418086)
    • Contributed Indexing:
      Keywords: Colombia; Global burden of disease; Respiratory syncytial virus
    • Publication Date:
      Date Created: 20201110 Date Completed: 20210514 Latest Revision: 20210514
    • Publication Date:
      20240105
    • Accession Number:
      PMC7654061
    • Accession Number:
      10.1186/s12889-020-09796-x
    • Accession Number:
      33167966